Mary Beth Harler - 14 Apr 2024 Form 3 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Head, Research & Autoimmunity
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
14 Apr 2024
Net transactions value
$0
Form type
3
Filing time
23 Apr 2024, 19:30:32 UTC
Next filing
18 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IGMS Common Stock 86,797 14 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IGMS Stock Option (right to buy) 14 Apr 2024 Common Stock 200,000 $61.45 Direct F2
holding IGMS Stock Option (right to buy) 14 Apr 2024 Common Stock 75,000 $17.11 Direct F3
holding IGMS Stock Option (right to buy) 14 Apr 2024 Common Stock 52,500 $12.86 Direct F4
holding IGMS Stock Option (right to buy) 14 Apr 2024 Common Stock 92,500 $9.95 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F2 1/4th of the shares subject to the option vested on October 11, 2022 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.
F3 1/48th of the shares subject to the option vested on April 12, 2022 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.
F4 1/48th of the shares subject to the option vested on April 12, 2023 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.
F5 1/48th of the shares subject to the option vested on April 12, 2024 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney